Molina Healthcare, Inc.

NYSE:MOH Voorraadrapport

Marktkapitalisatie: US$16.9b

Molina Healthcare Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Joe Zubretsky

Algemeen directeur

US$21.5m

Totale compensatie

Percentage CEO-salaris7.0%
Dienstverband CEO7yrs
Eigendom CEO0.6%
Management gemiddelde ambtstermijn6yrs
Gemiddelde ambtstermijn bestuur9.3yrs

Recente managementupdates

Recent updates

Analyzing And Valuing Molina Healthcare As A Solid Company

Nov 13

Here's What Analysts Are Forecasting For Molina Healthcare, Inc. (NYSE:MOH) After Its Third-Quarter Results

Oct 27
Here's What Analysts Are Forecasting For Molina Healthcare, Inc. (NYSE:MOH) After Its Third-Quarter Results

Molina Healthcare Q3 Earnings Preview - Cost Fears Flare Up

Oct 18

Returns On Capital Signal Tricky Times Ahead For Molina Healthcare (NYSE:MOH)

Oct 10
Returns On Capital Signal Tricky Times Ahead For Molina Healthcare (NYSE:MOH)

Are Investors Undervaluing Molina Healthcare, Inc. (NYSE:MOH) By 48%?

Sep 11
Are Investors Undervaluing Molina Healthcare, Inc. (NYSE:MOH) By 48%?

Does Molina Healthcare (NYSE:MOH) Deserve A Spot On Your Watchlist?

Aug 15
Does Molina Healthcare (NYSE:MOH) Deserve A Spot On Your Watchlist?

Molina Healthcare: Health Insurer Selling For A Discount

Jul 25

Molina Healthcare, Inc.'s (NYSE:MOH) Subdued P/E Might Signal An Opportunity

Jul 16
Molina Healthcare, Inc.'s (NYSE:MOH) Subdued P/E Might Signal An Opportunity

Molina Healthcare (NYSE:MOH) Is Reinvesting At Lower Rates Of Return

May 27
Molina Healthcare (NYSE:MOH) Is Reinvesting At Lower Rates Of Return

Molina Healthcare: Stock To Rise As Strategies Drive Strong Future Growth

May 06

Revenue Beat: Molina Healthcare, Inc. Beat Analyst Estimates By 5.3%

Apr 26
Revenue Beat: Molina Healthcare, Inc. Beat Analyst Estimates By 5.3%

Molina Healthcare (NYSE:MOH) Seems To Use Debt Rather Sparingly

Apr 15
Molina Healthcare (NYSE:MOH) Seems To Use Debt Rather Sparingly

Molina Healthcare, Inc.'s (NYSE:MOH) Popularity With Investors Is Clear

Apr 01
Molina Healthcare, Inc.'s (NYSE:MOH) Popularity With Investors Is Clear

Should You Be Adding Molina Healthcare (NYSE:MOH) To Your Watchlist Today?

Mar 18
Should You Be Adding Molina Healthcare (NYSE:MOH) To Your Watchlist Today?

An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 35% Undervalued

Mar 04
An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 35% Undervalued

Molina Healthcare: Attractive Risk-Reward Calculus Over All Horizons

Jan 26

Molina Healthcare (NYSE:MOH) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16
Molina Healthcare (NYSE:MOH) Will Be Hoping To Turn Its Returns On Capital Around

Does Molina Healthcare (NYSE:MOH) Have A Healthy Balance Sheet?

Jan 02
Does Molina Healthcare (NYSE:MOH) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Molina Healthcare, Inc. (NYSE:MOH)

Dec 20
Investors Still Waiting For A Pull Back In Molina Healthcare, Inc. (NYSE:MOH)

Here's Why We Think Molina Healthcare (NYSE:MOH) Might Deserve Your Attention Today

Dec 06
Here's Why We Think Molina Healthcare (NYSE:MOH) Might Deserve Your Attention Today

An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 46% Undervalued

Nov 08
An Intrinsic Calculation For Molina Healthcare, Inc. (NYSE:MOH) Suggests It's 46% Undervalued

Molina Healthcare Q3: Robust Growth Potential Yet Underrated Compared To Peers

Oct 30

Shareholders Are Optimistic That Molina Healthcare (NYSE:MOH) Will Multiply In Value

Oct 11
Shareholders Are Optimistic That Molina Healthcare (NYSE:MOH) Will Multiply In Value

Molina Healthcare: Stable State Governments Contracts, And Undervalued

Sep 11

We Think Molina Healthcare (NYSE:MOH) Can Manage Its Debt With Ease

Sep 08
We Think Molina Healthcare (NYSE:MOH) Can Manage Its Debt With Ease

Here's Why Molina Healthcare (NYSE:MOH) Has Caught The Eye Of Investors

Aug 21
Here's Why Molina Healthcare (NYSE:MOH) Has Caught The Eye Of Investors

Molina Healthcare: A Hidden Compounder In Managed Healthcare

Jul 17

Investors Shouldn't Overlook Molina Healthcare's (NYSE:MOH) Impressive Returns On Capital

Jul 09
Investors Shouldn't Overlook Molina Healthcare's (NYSE:MOH) Impressive Returns On Capital

Is There An Opportunity With Molina Healthcare, Inc.'s (NYSE:MOH) 43% Undervaluation?

May 29
Is There An Opportunity With Molina Healthcare, Inc.'s (NYSE:MOH) 43% Undervaluation?

Here's Why We Think Molina Healthcare (NYSE:MOH) Is Well Worth Watching

May 15
Here's Why We Think Molina Healthcare (NYSE:MOH) Is Well Worth Watching

Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet

May 01
Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet

We Think Molina Healthcare (NYSE:MOH) Might Have The DNA Of A Multi-Bagger

Mar 31
We Think Molina Healthcare (NYSE:MOH) Might Have The DNA Of A Multi-Bagger

Molina Healthcare Is Still Appealing In The Face Of Medicaid Redetermination

Feb 21

Is Now The Time To Put Molina Healthcare (NYSE:MOH) On Your Watchlist?

Feb 13
Is Now The Time To Put Molina Healthcare (NYSE:MOH) On Your Watchlist?

Molina Healthcare Non-GAAP EPS of $4.10 beats by $0.08, revenue of $8.22B beats by $350M

Feb 08

Molina Healthcare (NYSE:MOH) Could Easily Take On More Debt

Jan 29
Molina Healthcare (NYSE:MOH) Could Easily Take On More Debt

Molina Healthcare takes $200M impairment on its leased space

Dec 29

Molina Healthcare (NYSE:MOH) Could Become A Multi-Bagger

Nov 23
Molina Healthcare (NYSE:MOH) Could Become A Multi-Bagger

Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet

Oct 25
Molina Healthcare (NYSE:MOH) Has A Rock Solid Balance Sheet

Molina Healthcare: Sacrificing Dividend For Growth Can Pay Off

Oct 20

Molina initiated at overweight at JP Morgan on recent Medicaid contracts

Oct 04

When Should You Buy Molina Healthcare, Inc. (NYSE:MOH)?

Sep 26
When Should You Buy Molina Healthcare, Inc. (NYSE:MOH)?

Molina Healthcare of New Mexico partners with Pyx Health

Sep 13

Molina Healthcare reaches 52-week high; up 29% over last year

Aug 26

A Look At The Fair Value Of Molina Healthcare, Inc. (NYSE:MOH)

Aug 17
A Look At The Fair Value Of Molina Healthcare, Inc. (NYSE:MOH)

Why The 22% Return On Capital At Molina Healthcare (NYSE:MOH) Should Have Your Attention

Aug 04
Why The 22% Return On Capital At Molina Healthcare (NYSE:MOH) Should Have Your Attention

Analyse CEO-vergoeding

Hoe is Joe Zubretsky's beloning veranderd ten opzichte van Molina Healthcare's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

US$1b

Jun 30 2024n/an/a

US$1b

Mar 31 2024n/an/a

US$1b

Dec 31 2023US$21mUS$2m

US$1b

Sep 30 2023n/an/a

US$931m

Jun 30 2023n/an/a

US$916m

Mar 31 2023n/an/a

US$855m

Dec 31 2022US$22mUS$2m

US$792m

Sep 30 2022n/an/a

US$839m

Jun 30 2022n/an/a

US$752m

Mar 31 2022n/an/a

US$689m

Dec 31 2021US$20mUS$2m

US$659m

Sep 30 2021n/an/a

US$590m

Jun 30 2021n/an/a

US$632m

Mar 31 2021n/an/a

US$723m

Dec 31 2020US$18mUS$1m

US$673m

Sep 30 2020n/an/a

US$807m

Jun 30 2020n/an/a

US$797m

Mar 31 2020n/an/a

US$717m

Dec 31 2019US$18mUS$1m

US$737m

Sep 30 2019n/an/a

US$770m

Jun 30 2019n/an/a

US$792m

Mar 31 2019n/an/a

US$798m

Dec 31 2018US$15mUS$1m

US$707m

Sep 30 2018n/an/a

US$244m

Jun 30 2018n/an/a

-US$50m

Mar 31 2018n/an/a

-US$482m

Dec 31 2017US$20mUS$175k

-US$512m

Compensatie versus markt: De totale vergoeding ($USD 21.49M ) Joe } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.73M ).

Compensatie versus inkomsten: De vergoeding van Joe is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Joe Zubretsky (67 yo)

7yrs

Tenure

US$21,491,723

Compensatie

Mr. Joseph Michael Zubretsky, also known as Joe, has been President, Chief Executive Officer and Director of Molina Healthcare, Inc. since November 6, 2017. Mr. Zubretsky served as President and Chief Exec...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Joseph Zubretsky
President7yrsUS$21.49m0.61%
$ 103.1m
Mark Keim
Senior EVP3.8yrsUS$6.40m0.083%
$ 14.0m
James Woys
Senior EVP & COO1.5yrsUS$5.54m0.094%
$ 15.8m
Maurice Hebert
Chief Accounting Officer6.2yrsUS$1.27m0.017%
$ 2.8m
Jeffrey Barlow
Chief Legal Officer & Corporate Secretary14.3yrsUS$4.89m0.12%
$ 19.5m
Jeffrey Geyer
Head of Investor Relationsno datageen gegevensgeen gegevens
Joann Zarza-Garrido
Vice President of Compliance18.3yrsgeen gegevensgeen gegevens
Larry Anderson
Executive VP & Chief Human Resources Officer5.8yrsgeen gegevensgeen gegevens
Keith Wilson
Chief Medical Officer10.3yrsgeen gegevensgeen gegevens
John Kotal
Chief Operating Officer of Molina Healthcare of Californiano datageen gegevensgeen gegevens
David Reynolds
Senior Vice President of Health Plans4.8yrsgeen gegevensgeen gegevens
Jason Dees
Executive VP of Marketplace & Chief Medical Officer4.8yrsgeen gegevensgeen gegevens

6.0yrs

Gemiddelde duur

61yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van MOH is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Joseph Zubretsky
President7yrsUS$21.49m0.61%
$ 103.1m
Dale Wolf
Independent Non-Executive Chairman of the Board11.7yrsUS$545.46k0.027%
$ 4.5m
Daniel Cooperman
Independent Director11.7yrsUS$342.96k0.011%
$ 1.8m
Steven Orlando
Independent Director19yrsUS$380.46k0.034%
$ 5.8m
Ronna Romney
Independent Vice Chair of the Board21.8yrsUS$385.46k0.030%
$ 5.1m
Barbara Brasier
Independent Director5.5yrsUS$347.96k0.0071%
$ 1.2m
Richard Zoretic
Independent Director6.3yrsUS$347.96k0.012%
$ 2.0m
Stephen Lockhart
Independent Director3.5yrsUS$332.96k0.0046%
$ 766.8k
Richard Schapiro
Independent Director9.3yrsUS$357.96k0.020%
$ 3.4m

9.3yrs

Gemiddelde duur

68yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van MOH wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.3 jaar).